If a platform does not publicly disclose its privacy practices or does not mention HIPAA compliance , that is a red flag worth taking seriously
Medicare already covers GLP-1s for non-weight-loss indications, with spending on Ozempic alone reaching $4.6 billion in 2022
References References TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial Retatrutide in patients with obesity and MASLD Body composition outcomes of Retatrutide in patients with obesity Retatrutide in type 2 diabetes efficacy and glucose response Sub-analysis of the Phase 2 trial in Nature Medicine ClinicalTrials.gov: Ongoing global studies on weight loss, cardiovascular risk, and diabetes outcomes Synonyms: Retatrutide, 2381089-83-2, EX-A7826E, GTPL13769 Research & background Independent, research-focused reading
Liraglutide reduces alcohol consumption, anxiety, memory impairment, and synapse loss in alcohol dependent mice
The message is simple: Take this shot and the weight will disappear